11 Jul 2018 10:38
ADAMAS FINANCE ASIA LIMITED
RESULT OF GENERAL MEETING
APPROVAL OF DISPOSAL OF GLOBAL PHARM INTEREST
Further to the announcement on 15 June 2018 in relation to the proposed disposal of the interest in Global Pharm, the Company is pleased to announce that the resolutions proposed at the General Meeting held earlier today were duly passed and that the Disposal has thereby been approved.
Completion of the Disposal and the associated issue of 17,746,479 new Ordinary Shares at a price of US$0.71 per share to Fortune Insight Limited will take place in due course.
A further announcement will be made when appropriate.
Capitalised terms used in this announcement have the meaning given to them in the announcement of 15 June 2018.
Enquiries:
Adamas Finance Asia Limited John Croft |
+44 (0)1825 830587 | ||||
Nominated Adviser |
| ||||
WH Ireland Limited Tim Feather James Sinclair-Ford | +44 (0) 113 394 6600 | ||||
Broker |
| ||||
| +44 (0) 20 7186 9967 | ||||
Public Relations Advisers |
| ||||
Buchanan Charles Ryland Henry Wilson | +44 (0) 20 7466 5000 |
About Adamas Finance Asia ("ADAM")
ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments. It aims to provide uncorrelated returns through a combination of capital growth and dividend income from a broad spectrum of national geographies and asset classes.